Inova Schar Cancer’s pulmonary nodule program saves lives

Male doctor listening to senior man's lungs in exam room

Study at a glance Inova’s incidental lung nodule program has shown a 76% reduction in time from identification to diagnosis compared to standard referral pathways. This study showed an improvement in early-stage diagnosis of lung cancer when identified through Inova’s incidental lung nodule program. • 9,303 patients identified with incidental lung nodules • 134-day reduction…

Read More

Subspecialized expertise for complex cardiopulmonary disease

Multidisciplinary pulmonary expertise supports diagnostic evaluation, treatment planning and longitudinal care Advanced lung disease and cardiovascular disease frequently intersect, with overlapping clinical presentations that can complicate diagnosis, risk stratification and treatment planning. Progressive dysfunction in either system can accelerate decline in the other, contributing to increased morbidity and mortality. For physicians managing these complex patients,…

Read More

Inova accelerates care transformation for heart failure

Heart failure is a major focus for Inova Schar Heart and Vascular’s care transformation efforts. This involves collaboration across multiple domains to implement a deliberate and thoughtful guideline-directed therapeutic approach to ensure every patient with heart failure receives the best care possible. The result is a system-wide comprehensive care model for heart failure. “We looked…

Read More

Inova instrumental in new IPF study findings

TETON pivotal studies meet primary end point In two landmark phase 3 trials, nebulized Tyvaso® (treprostinil) Inhalation Solution demonstrated superiority over placebo for the primary endpoint of change in absolute forced vital capacity at 52 weeks in patients with idiopathic pulmonary fibrosis (IPF). In addition, the treatment arm demonstrated a reduction in the risk of clinical worsening, with positive results observed across…

Read More

Expanded capabilities for evaluation of INOCA, microvascular dysfunction and vasospasm

Inova Schar Heart and Vascular has expanded its diagnostic capabilities for patients with angina, ischemic symptoms and nonobstructive coronary artery disease by implementing advanced coronary physiologic assessment in its catheterization laboratories and opening a dedicated outpatient cardiac PET/CT diagnostic imaging site. Together, these capabilities support more precise evaluation of ischemia with no obstructive coronary arteries…

Read More

Inova announces recipients of annual Community Health Opportunities funding in support of local nonprofits

Representatives from the 2026 Inova Community Health Opportunities funding recipients with oversized checks and Inova Division Community Health leaders

Fairfax, VA – Inova today announced Community Health Opportunities funding for 26 nonprofit organizations working to address the social drivers of health and improve the well-being of Northern Virginia residents. Administered through Inova’s Division of Community Health, the annual funding opportunity supports community-based organizations that provide essential services to under-resourced populations and help address priorities…

Read More

Inova Schar Cancer President John Deeken, MD, named to Modern Healthcare’s 50 Most Influential Clinical Executives List

FAIRFAX, Va. — John Deeken, MD, President of Inova Schar Cancer and co-director of the Inova Schar Head and Neck Cancer Program, has been named to Modern Healthcare’s 2026 list of the “50 Most Influential Clinical Executive.” This national recognition honors physician and clinical leaders whose impact extends beyond their own organizations to help shape…

Read More